Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FPHAX vs FSPHX overlap: 33% of top holdings shared

Bottom line

How much do FPHAX and FSPHX overlap?

33% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 55.8% of FPHAX's assets and 23.3% of FSPHX's. They share a meaningful core but differ in the rest of the portfolio.

FSPHX holds far more positions (152 vs 57), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FPHAXFSPHX
Weight overlap (top 25)33%
Shared holdings8
Weight in shared holdings55.8%23.3%
Total positions57152
Expense ratio0.67%0.62%
Holdings as ofMay 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Holdings FPHAX and FSPHX have in common

Holding% of FPHAX% of FSPHXOverlap
ELI LILLY and CO28.78%8.03%8.03%
Viatris Inc5.45%1.20%1.20%
Ucb Sa5.09%2.03%2.03%
MERCK and CO INC4.74%1.60%1.60%
Gilead Sciences Inc3.97%2.21%2.21%
JOHNSON and JOHNSON3.77%4.91%3.77%
Fidelity Revere Street Trust2.44%2.17%2.17%
Moderna Inc1.57%1.18%1.18%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FPHAX

  1. Gsk Plc — 8.17%
  2. Roche Holding Ag — 4.54%
  3. Legend Biotech Corp — 4.53%
  4. Astrazeneca Plc — 4.22%
  5. Elanco Animal Health Inc — 4.15%
  6. Jazz Pharmaceuticals Plc — 4.09%
  7. Royalty Pharma Plc — 2.67%
  8. Intellia Therapeutics Inc — 1.19%
  9. Beam Therapeutics Inc — 1.10%
  10. Axsome Therapeutics Inc — 1.08%
  11. Biontech Se — 1.04%
  12. Xenon Pharmaceuticals Inc — 0.82%
  13. Ocular Therapeutix Inc — 0.80%
  14. Idexx Laboratories Inc — 0.61%
  15. Swedish Orphan Biovitrum Ab — 0.54%

Only in FSPHX

  1. Danaher Corp — 6.89%
  2. Thermo Fisher Scientific Inc — 4.33%
  3. Unitedhealth Group Inc — 3.49%
  4. Alnylam Pharmaceuticals Inc — 2.40%
  5. Boston Scientific Corp — 2.17%
  6. Ascendis Pharma A/s — 2.17%
  7. Abbvie Inc — 2.03%
  8. Bio Techne Corp — 1.70%
  9. Argenx Se — 1.56%
  10. Cvs Health Corp — 1.29%
  11. Nuvalent Inc — 1.28%
  12. Natera Inc — 1.27%
  13. Brightspring Health Services Inc — 1.23%
  14. Cencora Inc — 1.14%
  15. West Pharmaceutical Svcs Inc — 1.12%

Asset mix

Asset typeFPHAXFSPHX
Stocks98.7%97.7%
Cash & short-term funds2.6%2.4%
Preferred stock0.7%2.0%
Bonds0.1%0.1%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Country mix

CountryFPHAXFSPHX
US64.8%87.0%
GB15.1%2.1%
BE5.3%2.0%
CH4.5%1.4%
KY4.5%1.4%
IE4.1%1.0%
NL0.3%2.4%
DK0.3%2.2%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do FPHAX and FSPHX overlap?
About 33% by weight. 8 securities appear in both funds' top 25 holdings; they make up 55.8% of FPHAX's assets and 23.3% of FSPHX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FPHAX and FSPHX have in common?
The largest shared holdings are ELI LILLY and CO, JOHNSON and JOHNSON, Gilead Sciences Inc, Fidelity Revere Street Trust, Ucb Sa.
Should I own both FPHAX and FSPHX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FPHAX or FSPHX?
FSPHX is broader, with 152 positions versus 57 for FPHAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.